Utility of Cement Augmentation via Percutaneous Fenestrated Pedicle Screws for Stabilization of Cancer-Related Spinal Instability.


Journal

Operative neurosurgery (Hagerstown, Md.)
ISSN: 2332-4260
Titre abrégé: Oper Neurosurg (Hagerstown)
Pays: United States
ID NLM: 101635417

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 01 02 2018
accepted: 20 09 2018
pubmed: 7 12 2018
medline: 20 9 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Cancer patients experience pathological fractures and the typical poor bone quality frequently complicates stabilization. Methods for overcoming screw failure include utilization of fenestrated screws that permit the injection of bone cement into the vertebral body to augment fixation. To evaluate the safety and efficacy of cement augmentation via fenestrated screws. A retrospective chart review of patients with neoplastic spinal instability who underwent percutaneous instrumented stabilization with cement augmentation using fenestrated pedicle screws. Patient demographic and treatment data and intraoperative and postoperative complications were evaluated by chart review and radiographic evaluation. Prospectively collected patient reported outcomes (PRO) were evaluated at short (2- <6 mo) and long term (6-12 mo). Cement augmentation was performed in 216 fenestrated pedicle screws in 53 patients. Three patients required reoperation. One patient had an asymptomatic screw fracture at 6 mo postoperatively that did not require intervention. No cases of lucency around the pedicle screws, rod fractures, or cement extravasation into the spinal canal were observed. Eight cases of asymptomatic, radiographically-detected venous extravasation were found. Systemic complications included a pulmonary cement embolism, a lower extremity deep vein thrombosis, and a postoperative mortality secondary to pulmonary failure from widespread metastatic pulmonary infiltration. Significant improvement in PRO measures was found in short- and long-term analysis. Cement augmentation of pedicle screws is an effective method to enhance the durability of spinal constructs in the cancer population. Risks include cement extravasation into draining blood vessels, but risk of clinically significant extravasation appears to be exceedingly low.

Sections du résumé

BACKGROUND
Cancer patients experience pathological fractures and the typical poor bone quality frequently complicates stabilization. Methods for overcoming screw failure include utilization of fenestrated screws that permit the injection of bone cement into the vertebral body to augment fixation.
OBJECTIVE
To evaluate the safety and efficacy of cement augmentation via fenestrated screws.
METHODS
A retrospective chart review of patients with neoplastic spinal instability who underwent percutaneous instrumented stabilization with cement augmentation using fenestrated pedicle screws. Patient demographic and treatment data and intraoperative and postoperative complications were evaluated by chart review and radiographic evaluation. Prospectively collected patient reported outcomes (PRO) were evaluated at short (2- <6 mo) and long term (6-12 mo).
RESULTS
Cement augmentation was performed in 216 fenestrated pedicle screws in 53 patients. Three patients required reoperation. One patient had an asymptomatic screw fracture at 6 mo postoperatively that did not require intervention. No cases of lucency around the pedicle screws, rod fractures, or cement extravasation into the spinal canal were observed. Eight cases of asymptomatic, radiographically-detected venous extravasation were found. Systemic complications included a pulmonary cement embolism, a lower extremity deep vein thrombosis, and a postoperative mortality secondary to pulmonary failure from widespread metastatic pulmonary infiltration. Significant improvement in PRO measures was found in short- and long-term analysis.
CONCLUSION
Cement augmentation of pedicle screws is an effective method to enhance the durability of spinal constructs in the cancer population. Risks include cement extravasation into draining blood vessels, but risk of clinically significant extravasation appears to be exceedingly low.

Identifiants

pubmed: 30508168
pii: 5227602
doi: 10.1093/ons/opy186
pmc: PMC7311793
doi:

Substances chimiques

Bone Cements 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

593-599

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2018 by the Congress of Neurological Surgeons.

Références

Eur Spine J. 2009 Sep;18(9):1257-65
pubmed: 19575243
Oncol Nurs Forum. 2003 Mar-Apr;30(2):325-30
pubmed: 12692666
Spine (Phila Pa 1976). 2010 Oct 15;35(22):E1221-9
pubmed: 20562730
Cancer. 2000 Oct 1;89(7):1634-46
pubmed: 11013380
J Neurosurg Spine. 2010 Apr;12(4):421-30
pubmed: 20367379
Spine J. 2015 Jul 01;15(7):1609-17
pubmed: 25828478
Neurooncol Pract. 2018 May;5(2):104-113
pubmed: 29770224
J Clin Neurosci. 2011 Jun;18(6):763-7
pubmed: 21507652
Spine J. 2015 Jun 1;15(6):1432-45
pubmed: 25797809
Lancet Oncol. 2011 Mar;12(3):225-35
pubmed: 21333599
Ann Acad Med Singapore. 1994 Mar;23(2):129-38
pubmed: 8080219
J Neurosurg. 2003 Jan;98(1 Suppl):21-30
pubmed: 12546384
J Surg Oncol. 2013 Dec;108(7):499-503
pubmed: 23982866
J Neurosurg Spine. 2018 Jan;28(1):72-78
pubmed: 29087812
Orthop Surg. 2012 Aug;4(3):182-9
pubmed: 22927153
Spine J. 2018 Jul;18(7):1109-1115
pubmed: 29122701
AJR Am J Roentgenol. 2004 Oct;183(4):1097-102
pubmed: 15385313
Neurosurgery. 2007 Sep;61(3):531-7; discussion 537-8
pubmed: 17881965
Spine J. 2014 Sep 1;14(9):1850-9
pubmed: 24216397
J Thorac Cardiovasc Surg. 2012 Apr;143(4):e22-4
pubmed: 22424531
J Neurosurg Spine. 2016 Nov;25(5):610-619
pubmed: 27314551
Orthop Surg. 2014 Aug;6(3):187-95
pubmed: 25179352
Thromb Res. 2004;114(3):179-84
pubmed: 15342214
Neurosurg Focus. 2017 Jan;42(1):E16
pubmed: 28041327

Auteurs

Ori Barzilai (O)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Lily McLaughlin (L)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Eric Lis (E)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

Anne S Reiner (AS)

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York.

Mark H Bilsky (MH)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Neurological Surgery, Weill Cornell Medical College, New York, New York.

Ilya Laufer (I)

Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Neurological Surgery, Weill Cornell Medical College, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH